company background image
539268

Syngene International BSE:539268 Stock Report

Last Price

₹609.00

Market Cap

₹241.9b

7D

1.5%

1Y

3.2%

Updated

27 Nov, 2022

Data

Company Financials +
539268 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

539268 Stock Overview

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally.

Syngene International Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Syngene International
Historical stock prices
Current Share Price₹609.00
52 Week High₹682.25
52 Week Low₹508.10
Beta0.70
1 Month Change-0.55%
3 Month Change0.85%
1 Year Change3.19%
3 Year Change91.99%
5 Year Change121.90%
Change since IPO292.40%

Recent News & Updates

Recent updates

Shareholder Returns

539268IN Life SciencesIN Market
7D1.5%1.5%0.9%
1Y3.2%-27.0%6.2%

Return vs Industry: 539268 exceeded the Indian Life Sciences industry which returned -27% over the past year.

Return vs Market: 539268 underperformed the Indian Market which returned 6.2% over the past year.

Price Volatility

Is 539268's price volatile compared to industry and market?
539268 volatility
539268 Average Weekly Movement3.7%
Life Sciences Industry Average Movement5.9%
Market Average Movement5.6%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market3.6%

Stable Share Price: 539268 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 539268's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19935,975Jonathan Hunthttps://www.syngeneintl.com

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services.

Syngene International Limited Fundamentals Summary

How do Syngene International's earnings and revenue compare to its market cap?
539268 fundamental statistics
Market Cap₹241.88b
Earnings (TTM)₹4.28b
Revenue (TTM)₹28.12b

56.6x

P/E Ratio

8.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
539268 income statement (TTM)
Revenue₹28.12b
Cost of Revenue₹8.90b
Gross Profit₹19.22b
Other Expenses₹14.94b
Earnings₹4.28b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Jan 23, 2023

Earnings per share (EPS)10.77
Gross Margin68.34%
Net Profit Margin15.21%
Debt/Equity Ratio23.5%

How did 539268 perform over the long term?

See historical performance and comparison

Dividends

0.08%

Current Dividend Yield

5%

Payout Ratio